Xiaodi Guo

405 total citations
23 papers, 227 citations indexed

About

Xiaodi Guo is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Hepatology. According to data from OpenAlex, Xiaodi Guo has authored 23 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Hepatology. Recurrent topics in Xiaodi Guo's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Diabetes Management and Education (6 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Xiaodi Guo is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Diabetes Management and Education (6 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Xiaodi Guo collaborates with scholars based in China, United States and United Kingdom. Xiaodi Guo's co-authors include Wendong Li, Wei Li, Ying Teng, Xiaoyan Ding, Wei Sun, Yanjun Shen, Jinglong Chen, Xiaomin Liu, Linlin Zheng and Qiang Su and has published in prestigious journals such as Cancer, Annals of Oncology and Biomedicine & Pharmacotherapy.

In The Last Decade

Xiaodi Guo

20 papers receiving 224 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaodi Guo China	8	110	57	48	39	35	23	227
Dorota Broniszczak Poland	10	192 1.7×	61 1.1×	13 0.3×	47 1.2×	67 1.9×	24	314
Ahmed Issam Ali Egypt	7	108 1.0×	116 2.0×	8 0.2×	31 0.8×	26 0.7×	22	238
Tai-Jong Chao Taiwan	5	95 0.9×	32 0.6×	64 1.3×	50 1.3×	31 0.9×	8	232
Manuel Delgado Spain	9	112 1.0×	133 2.3×	24 0.5×	35 0.9×	39 1.1×	19	269
Masakuni Tateyama Japan	8	282 2.6×	274 4.8×	19 0.4×	23 0.6×	35 1.0×	24	382
Kanwarpreet Tandon United States	10	54 0.5×	97 1.7×	23 0.5×	46 1.2×	68 1.9×	21	263
Xuwei Hong China	9	14 0.1×	45 0.8×	19 0.4×	51 1.3×	45 1.3×	21	233
Xiaoli Zhu China	10	207 1.9×	91 1.6×	70 1.5×	58 1.5×	30 0.9×	48	294
P C Huettner United States	10	43 0.4×	93 1.6×	13 0.3×	39 1.0×	31 0.9×	13	297
Nikolaos J. Tsagarakis Greece	10	26 0.2×	79 1.4×	34 0.7×	30 0.8×	69 2.0×	24	272

Countries citing papers authored by Xiaodi Guo

Since Specialization

Citations

This map shows the geographic impact of Xiaodi Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodi Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodi Guo more than expected).

Fields of papers citing papers by Xiaodi Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodi Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodi Guo. The network helps show where Xiaodi Guo may publish in the future.

Co-authorship network of co-authors of Xiaodi Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodi Guo. A scholar is included among the top collaborators of Xiaodi Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodi Guo. Xiaodi Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ni, Ying, et al.. (2025). Experiences and opinions of adults with type 1 diabetes on the android-based open-source closed-loop system in China: a qualitative study. BMJ Open. 15(1). e094333–e094333. 1 indexed citations

Zhao, Xiaoyan, et al.. (2025). Barriers and Facilitators to Physical Activity in People With Young‐Onset (Aged 18‐40 Years) Type 2 Diabetes: A Qualitative Study. Journal of Clinical Nursing. 34(6). 2386–2399.

Zhang, Yao, et al.. (2025). Development and validation of a hypoglycemia risk prediction tool for hospitalized patients with type 2 diabetes mellitus treated with insulin. World Journal of Diabetes. 16(9). 104290–104290.

Sun, Shasha, et al.. (2024). Lenvatinib combined with sintilimab plus transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma. World Journal of Clinical Cases. 12(2). 285–292. 1 indexed citations

Liu, Qiao, et al.. (2024). Effectiveness of acceptance and commitment therapy in people with type 2 diabetes mellitus: A systematic review and meta‐analysis. Worldviews on Evidence-Based Nursing. 21(4). 454–466. 3 indexed citations

Zhao, Xiaoyan, et al.. (2023). Serial mediation roles of empowerment and self‐care activities connecting health literacy, quality of life, and glycemic control in people with type 2 diabetes. Worldviews on Evidence-Based Nursing. 21(3). 330–337. 2 indexed citations

Song, Rui, Xiaoyou Chen, Liang Xiao, et al.. (2023). Nasal spray of an IgM‐like ACE2 fusion protein HH‐120 prevents SARS‐CoV‐2 infection: Two investigator‐initiated postexposure prophylaxis trials. Journal of Medical Virology. 95(12). 1 indexed citations

Song, Rui, Xiaoyou Chen, Xiaodi Guo, et al.. (2023). Nasal spray of an IgM‐like ACE2 fusion protein HH‐120 accelerates SARS‐CoV‐2 clearance: A single‐center propensity score‐matched cohort study. Journal of Medical Virology. 95(5). e28805–e28805. 7 indexed citations

Zhou, Lili, Yaoyao Liu, Qiang Ji, et al.. (2023). A lipid metabolism–based prognostic risk model for HBV–related hepatocellular carcinoma. Lipids in Health and Disease. 22(1). 46–46. 2 indexed citations

10.

Li, Wendong, Xiaoyan Ding, Wei Sun, et al.. (2022). CT-guided percutaneous chemical ablation combined with radiofrequency ablation for hepatocellular carcinomas in high-risk locations: lobaplatin vs. ethanol.. PubMed. 14(9). 6726–6736.

11.

Li, Shenglan, Jinyi Chen, Feng Chen, et al.. (2021). Liposomal honokiol promotes hair growth via activating Wnt3a/β-catenin signaling pathway and down regulating TGF-β1 in C57BL/6N mice. Biomedicine & Pharmacotherapy. 141. 111793–111793. 31 indexed citations

12.

Zhang, Yao, et al.. (2021). Dietary Knowledge, Attitude and Practice (KAP) Among the Family Members of Patients with Type 2 Diabetes Mellitus (T2DM) and Its Influence on the KAP of T2DM Patients. Diabetes Metabolic Syndrome and Obesity. Volume 14. 205–213. 10 indexed citations

13.

Ding, Xiaoyan, Wei Sun, Wei Li, et al.. (2021). Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first‐line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study. Cancer. 127(20). 3782–3793. 100 indexed citations

14.

Deng, Hongrong, Yao Zhang, Xiaodi Guo, et al.. (2021). Efficacy and Safety of a Decision Support Intervention for Basal Insulin Self-Titration Assisted by the Nurse in Outpatients with T2DM: A Randomized Controlled Trial. Diabetes Metabolic Syndrome and Obesity. Volume 14. 1315–1327. 6 indexed citations

15.

Guo, Xiaodi, et al.. (2020). Hepatotoxicity in patients with solid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitors plus chemotherapy, or chemotherapy alone: systematic review and meta-analysis. European Journal of Clinical Pharmacology. 76(10). 1345–1354. 18 indexed citations

16.

Ding, Xiaoyan, et al.. (2020). 171P Transarterial chemoembolization (TACE) plus lenvatinib versus TACE plus sorafenib for hepatocellular carcinoma (HCC) with portal vein tumour thrombus (PVTT): A prospective randomized study. Annals of Oncology. 31. S1306–S1306. 1 indexed citations

17.

Qian, Fang, Guiju Gao, Yangzi Song, et al.. (2020). Specific dynamic variations in the peripheral blood lymphocyte subsets in COVID-19 and severe influenza A patients: a retrospective observational study. BMC Infectious Diseases. 20(1). 910–910. 12 indexed citations

18.

Ding, Xiaoyan, Wei Sun, Jinglong Chen, et al.. (2020). Percutaneous Radiofrequency Ablation Combined With Transarterial Chemoembolization Plus Sorafenib for Large Hepatocellular Carcinoma Invading the Portal Venous System: A Prospective Randomized Study. Frontiers in Oncology. 10. 578633–578633. 12 indexed citations

19.

Sun, Wei, Xiaoyan Ding, Jinglong Chen, et al.. (2017). [The combination of percutaneous iohexol-ethanol injection with radiofrequency ablation for the treatment of primary liver cancer in high-risk locations].. PubMed. 39(9). 695–700. 1 indexed citations

20.

Wei, Ling, et al.. (2013). Clinical analysis of 230 cases of drug-induced liver injury. 12(11). 886–889. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact